Last viewed: ALT

Prices are updated after-hours

ALT

Altimmune, Inc.

ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

(0.0% 1d) (-26.2% 1m) (20.2% 1y) (0.0% 2d) (0.0% 3d) (-8.7% 7d) (18.07% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 488,468,521
http://www.altimmune.com
Sec Filling | Patents | 25 employees

(US) Altimmune, Inc. is a clinical stage immunotherapeutic biotechnology company. It focuses on the discovery and development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company's portfolio includes RespirVec and Densigen that targets to stimulate the elements of the human immune system to treat respiratory diseases, chronic infections, and cancer. Altimmune was founded in 1997 and is headquartered in Gaithersburg, MD.

cancer respiratory treatment injection respiratory diseases

add to watch list Paper trade email alert is off

Press-releases

Altimmune Announces Positive Lean Mass Preservation Data for Pemvidutide and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-27 (Crawled : 11:00) - globenewswire.com
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -20.35% | O: 7.63% H: 3.33% C: -4.51%
year positive financial results

Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -21.17% | O: -0.34% H: 7.46% C: 7.23%
report business year update financial results

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
PFE A | $25.39 -0.12% 0.24% 31M

|

Health Technology

| -10.4% | O: -0.21% H: 0.11% C: -1.06%
LLY | $745.95 -0.64% -0.81% 1.3M

|

Health Technology

| 2.23% | O: 0.9% H: 2.03% C: 1.89%
VERU | $1.42 22.41% 18.31% 6.9M

|

Health Technology

| 115.81% | O: -0.53% H: 2.22% C: -3.59%
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -30.19% | O: 0.3% H: 11.41% C: 9.8%
medical program

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Amplitude, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPL
Published: 2024-03-05 (Crawled : 23:00) - prnewswire.com
AMPL | $9.46 -0.32% -0.21% 300K

|

| -13.2% | O: 0.05% H: 1.44% C: 0.05%
ADM | $61.72 2.15% -0.52% 2.5M

|

Process Industries

| 13.64% | O: 0.56% H: 1.17% C: 0.73%
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -38.7% | O: 1.87% H: 2.75% C: -0.52%
deadline

ROSEN, NATIONAL TRIAL LAWYERS, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
Published: 2024-02-25 (Crawled : 20:20) - prnewswire.com
ADM | $61.72 2.15% -0.52% 2.5M

|

Process Industries

| 13.66% | O: -0.02% H: 0.3% C: -0.51%
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -25.11% | O: 13.59% H: 14.55% C: 8.33%
ALVR | $0.7421 -1.96% -2.28% 480K

|

Health Technology

| 6.02% | O: 0.0% H: 5.99% C: 3.18%
deadline trial

ROSEN, LEADING INVESTOR COUNSEL, Encourages Archer-Daniels-Midland Company Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ADM
Published: 2024-02-25 (Crawled : 20:20) - prnewswire.com
TWKS | $2.29 1.33% 1.31% 400K

|

| -50.66% | O: -1.09% H: 3.09% C: 1.77%
ADM | $61.72 2.15% -0.52% 2.5M

|

Process Industries

| 13.66% | O: -0.02% H: 0.3% C: -0.51%
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -25.11% | O: 13.59% H: 14.55% C: 8.33%
company deadline

ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Inquire About Securities Class Action Investigation - ALT
Published: 2024-02-25 (Crawled : 20:20) - prnewswire.com
TWKS | $2.29 1.33% 1.31% 400K

|

| -50.66% | O: -1.09% H: 3.09% C: 1.77%
ADM | $61.72 2.15% -0.52% 2.5M

|

Process Industries

| 13.66% | O: -0.02% H: 0.3% C: -0.51%
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -25.11% | O: 13.59% H: 14.55% C: 8.33%

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SAVA
Published: 2024-02-16 (Crawled : 00:20) - prnewswire.com
ALVR | $0.7421 -1.96% -2.28% 480K

|

Health Technology

| Email alert Add to watchlist
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| Email alert Add to watchlist
SAVA | $21.19 -0.38% -0.42% 910K

|

Health Technology

| Email alert Add to watchlist
trusted deadline

ROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVR
Published: 2024-02-16 (Crawled : 00:20) - prnewswire.com
ALVR | $0.7421 -1.96% -2.28% 480K

|

Health Technology

| Email alert Add to watchlist
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| Email alert Add to watchlist
TWKS | $2.29 1.33% 1.31% 400K

|

| Email alert Add to watchlist
deadline

Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | $745.95 -0.64% -0.81% 1.3M

|

Health Technology

| 19.0% | O: -0.51% H: 0.37% C: 0.32%
MDGL | $222.26 -2.66% -2.8% 220K

|

Health Technology

| -4.68% | O: 1.29% H: 0.35% C: -3.04%
HEPA | $2.1118 -0.85% -1.43% 30K

|

Health Technology

| 0.96% | O: -0.48% H: 7.69% C: 1.44%
ALT | $6.89 -2.13% -2.03% 2.7M

|

Commercial Services

| -31.37% | O: -0.8% H: 6.02% C: 0.6%
ALNY | News | $145.16 -0.11% -0.19% 400K

|

Health Technology

| -21.07% | O: 0.46% H: 3.04% C: 2.67%
ETNB | $8.88 -3.06% -2.92% 680K

|

Health Technology

| -13.37% | O: 1.19% H: 0.63% C: -0.72%
liver disease companies key growth market

See all

Last 15 days Sec forms

File Id

Form

Published Date

Transaction Date

Direction

Code

Amount Transacted

Owned Amount

Your Today's Watch List

Sign in to create a watchlist

Gainers vs Losers

59%

41%

Top 10 Gainers

AGBA | News | $1.03 157.5% 57.94% 120M

|

ZCMD | $1.45 5.84% 52.1% 2.3M

|

Commercial Services

INVO | $1.52 100.0% 51.13% 5M

|

Health Technology

ISPC | $0.421 97.65% 49.53% 37M

|

Professional, Scientific, and T...

WLGS | News | $0.5 45.65% 470K

|

OST | $0.509 23.81% 45.26% 90K

|

GDHG | $0.263 21.76% 40.66% 3.1M

|

XPON | News | $3.15 63.21% 37.74% 16M

|

TIRX | $0.8 65.02% 30.74% 58M

|

BNTC | News | $6.82 42.08% 30.64% 3.5M

|

Health Technology

Last 48 Hours Insiders Buying

ADMQ | $0.0532 -4.14% -40.18% 480K

|

| 10:30
AXR P 2400 | $22.17 2.69% 0.0% 5.5K

|

| 21:00
QCRH P 118 | $55.41 1.34% 1.31% 54K

|

| 18:01
VUZI P 7500 | $1.26 3.28% 3.17% 930K

|

Electronic Technology

| 18:00
RMCF | $3.5501 0.57% 2.22% 18K

|

Consumer Non-Durables

| 20:10

12 months watchlist earnings calendar